Viatris Inc
VTRS: XNAS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$14.00 | Pncjd | Bvzllpm |
Viatris Earnings: New Launches and Stabilized Generics Prove Enough To Offset Challenges
No-moat Viatris reported second-quarter results that were slightly ahead of our expectations. Total sales were down 4.8% year over year but up 1.5% on an operational basis (excluding foreign exchange and divestiture impacts). Our assumptions for the second half of the year remain largely the same, and we maintain our $13 fair value estimate.